Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.44 0.00%   SPY: 132.20 0.00%
Quote Spy MAXY NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Maxygen (MAXY)

@ May-22
Click the portfolio to add MAXY:
Close [X]
+ Add MAXY to Portfolio
  
  Last Trade: $5.82 0.00 (0.00%)
  Volume:
       
  Avg Volume: 119,770
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.00 - 0.00
  Open: 0.00
  Previous Close: 5.82
  52-wk Range: 5.11 - 6.20
  Market Cap: 158.5M
  P/E: -24.2
  Div Yield: $1.00 (0.00%)
Indexes
Biotechnology Stocks (-0.7%)
Spy MAXY

? Pro holders
? Member holders
? Items submitted
Additional MAXY resources



Customize Links
To see which Pros and tickerspy members own MAXY Sign up now
Latest MAXY Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Maxygen Dives After Codexis Distribution
MAXY  CDXS  MOTR  
Linked by Forbes - December 15, 06:13PM from (www.forbes.com)
Biotech hands off its 17% stake to shareholders.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Maxygen Reports Third Quarter 2010 Financial Results
MAXY  
Linked by BusinessWire - November 04, 04:10PM from (www.businesswire.com)
Maxygen, Inc. (Nasdaq:MAXY), a biopharmaceutical company focused on developing improved versions of protein drugs through  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Maxygen Announces Sale of MolecularBreeding™ Directed Evolution Platform Technology to Codexis
MAXY  CDXS  
Linked by BusinessWire - October 28, 04:10PM from (www.businesswire.com)
Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company focused on the development of improved protein drugs, today announced  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Maxygen Reports Second Quarter 2010 Financial Results
MAXY  
Linked by BusinessWire - August 04, 04:15PM from (www.businesswire.com)
Maxygen, Inc. (Nasdaq:MAXY), a biopharmaceutical company focused on developing improved versions of protein drugs through  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Maxygen Announces Expiration of Cangene’s Option to License MAXY-G34 for Acute Radiation Syndrome
MAXY  
Linked by BusinessWire - July 16, 06:50PM from (www.businesswire.com)
Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company focused on the development of improved protein drugs, today announced  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Maxygen Announces $10 Million Stock Repurchase Program
MAXY  
Linked by BusinessWire - May 27, 05:00PM from (www.businesswire.com)
Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company focused on the development of improved protein drugs, today announced  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Maxygen Reports First Quarter 2010 Financial Results
MAXY  
Linked by BusinessWire - May 06, 04:05PM from (www.businesswire.com)
Maxygen, Inc. (Nasdaq: MAXY), a biopharmaceutical company focused on developing improved versions of protein drugs through  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Maxygen Reports Fourth Quarter and Year End 2009 Financial Results
MAXY  
Linked by BusinessWire - March 11, 04:05PM from (www.businesswire.com)
Maxygen, Inc. (Nasdaq:MAXY), a biopharmaceutical company focused on developing improved versions of protein drugs through  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource